Alternative Anastrozole Target CYP4V2 Impairs Neurons in Preclinical Models of Inherited Tauopathy
Chiara Pedicone, Sarah A. Weitzman, Joshua Orrick, Derian A. Pugh, Alison Goate, Ross Leigh Cagan, Kathryn R. Bowles, Masahiro Sonoshita
This study identifies anastrozole's off-target CYP4V2 as a neuroprotective factor in tauopathy models by reducing Tau phosphorylation and oxidative stress.
bioRxiv · Nov 29, 2025 · PreprintNeuroscience